Literature DB >> 18418411

An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis".

Joerg Wenzel1, Thomas Tüting.   

Abstract

The term "interface dermatitis" (ID) involves a specific histological inflammatory pattern that is characterized by a cytotoxic lymphocytic infiltration and a hydropic degeneration of the basal epidermal layer. ID is typically seen in autoimmune skin disorders such as lichen planus (LP), cutaneous lupus erythematosus (CLE), and may also appear during immune reactions against drugs, viruses, and tumors. Recent studies have shown that the type-I IFN system is involved in cutaneous autoimmune diseases characterized by ID. IFNs induce the expression of proinflammatory cytokines and chemokines, which support the cellular immune response. The role of IFNs in ID is supported by a close morphological association between the expression pattern of IFN-inducible proteins and the distribution of CXCR3+ lymphocytes. The IFN-inducible chemokine CXCL10 is expressed in exactly those areas where cytotoxic lymphocytes invade the basal epidermis and cause keratinocyte death. A similar picture can be found in early herpes simplex viral skin lesions and viral warts, but also in "lichenoid" actinic keratosis and invasive squamous cell carcinoma. These data suggest that ID morphologically reflects a common IFN-driven cytotoxic attack affecting the basal keratinocytes under different conditions, which is important for antiviral and antitumor immune response, but is inappropriately activated in autoimmune skin disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418411     DOI: 10.1038/jid.2008.96

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  42 in total

1.  Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.

Authors:  Kathryn J Martires; Kristin Baird; Deborah E Citrin; Fran T Hakim; Steven Z Pavletic; Edward W Cowen
Journal:  Arch Dermatol       Date:  2011-09

Review 2.  A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection.

Authors:  Franck J Barrat; Lishan Su
Journal:  J Exp Med       Date:  2019-08-16       Impact factor: 14.307

3.  Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.

Authors:  Ayumu Yoshikawa; Katsumi Terashita; Kenichi Morikawa; Soichiro Matsuda; Takahiro Yamamura; Koichiro Sarashina; Shintaro Nakano; Yoshimitsu Kobayashi; Susumu Sogabe; Kazuhiro Takahashi; Shin Haba; Hisashi Oda; Tatsuro Takahashi; Takuto Miyagishima; Naoya Sakamoto
Journal:  Clin J Gastroenterol       Date:  2017-04-26

Review 4.  Dermatomyositis and type 1 interferons.

Authors:  Steven A Greenberg
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

5.  CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.

Authors:  Vadim A Villarroel; Naoko Okiyama; Gaku Tsuji; Jay T Linton; Stephen I Katz
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

6.  CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Authors:  Mehdi Rashighi; Priti Agarwal; Jillian M Richmond; Tajie H Harris; Karen Dresser; Ming-Wan Su; Youwen Zhou; April Deng; Christopher A Hunter; Andrew D Luster; John E Harris
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

7.  Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.

Authors:  Julia S Lehman; Shahrukh K Hashmi; Hillard M Lazarus; Rokea A El-Azhary; Lawrence E Gibson; William J Hogan; Mark R Litzow; Mrinal S Patnaik; Francis Buadi; Martha Q Lacy; Surendra Dasari; Patrick Vanderboom; Alexander Meves
Journal:  J Cutan Pathol       Date:  2017-09-14       Impact factor: 1.587

8.  Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin.

Authors:  J S Lehman; S Dasari; S S Damodaran; R A El-Azhary; L E Gibson; S K Hashmi; W J Hogan; S J Kenderian; M S Patnaik; M R Litzow; H M Lazarus; A Meves
Journal:  Clin Exp Dermatol       Date:  2018-10-02       Impact factor: 3.470

Review 9.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

Review 10.  Fueling autoimmunity: type I interferon in autoimmune diseases.

Authors:  Jeremy Di Domizio; Wei Cao
Journal:  Expert Rev Clin Immunol       Date:  2013-03       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.